Spatial transcriptomics uncovers the hybrid molecular identity, ciliated phenotype, and immune signature of adenomyosis lesions
Science Advances · 26.06.2026 · 12 (26)
DOI: 10.1126/sciadv.aea6379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 26.06.2026. Verfasst von Alison Maclean und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK. Hauptthemen laut MEDLINE: Adenomyosis, Cilia, Transcriptome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, Wellbeing of Women, National Institute of Health Research Academic Clinical Lectureship.
Abstract (Originalsprache)
Adenomyosis is a common gynecological condition characterized by ectopic endometrial-like tissue deep within the myometrium, causing debilitating symptoms. Treatment options are limited to hormones that primarily focus on symptom management only or invasive hysterectomy. Despite its prevalence, the pathogenesis of adenomyosis remains poorly understood, considerably impeding the development of targeted, true disease modifying treatments. Here, through spatial transcriptomics analysis of full-thickness human uterine wall biopsies ( n = 10), we demonstrate that adenomyosis lesions exhibit a distinct transcriptomic profile, intermediate between matched endometrium and myometrium, characterized by enhanced epithelial ciliation and altered biological pathways. We reveal that adenomyosis lesion transcriptome more closely resembles the endometrial basalis than the functionalis, marked by enriched olfactory signaling, dysregulated oxidative phosphorylation and adenosine triphosphate synthesis, and an altered immune microenvironment indicative of chronic inflammation. In silico drug screening identified candidate compounds capable of reversing the adenomyosis lesion transcriptomic signature. These findings offer previously unknown insights into the molecular landscape of adenomyosis lesions and lay the groundwork for development of targeted, lesion-specific therapies that may preserve the eutopic endometrium and offer alternatives to hysterectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
- Liverpool Women's NHS Foundation Trust, Liverpool, UK.
- Computational Biology Facility, Liverpool Shared Research Facilities, University of Liverpool, Liverpool L69 7ZB, UK.
- Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK.
ORCID-Profile: Alison Maclean, Emily Johnson, Eva Caamaño Gutiérrez, Dharani K Hapangama
Förderung
- Medical Research Council
- Wellbeing of Women
- National Institute of Health Research Academic Clinical Lectureship
- University Of Liverpool
Zitieren
APA
Maclean, A., Johnson, E., Rushworth, C., Hill, C. J., Caamaño Gutiérrez, E., & Hapangama, D. K. (2026). Spatial transcriptomics uncovers the hybrid molecular identity, ciliated phenotype, and immune signature of adenomyosis lesions. Science Advances, 12(26). https://doi.org/10.1126/sciadv.aea6379
Vancouver
Maclean A, Johnson E, Rushworth C, Hill CJ, Caamaño Gutiérrez E, Hapangama DK. Spatial transcriptomics uncovers the hybrid molecular identity, ciliated phenotype, and immune signature of adenomyosis lesions. Science Advances. 2026;12(26). doi:10.1126/sciadv.aea6379
BibTeX
@article{Maclean2026,
author = {Maclean, Alison and Johnson, Emily and Rushworth, Corie and Hill, Christopher J and Caamaño Gutiérrez, Eva and Hapangama, Dharani K},
title = {Spatial transcriptomics uncovers the hybrid molecular identity, ciliated phenotype, and immune signature of adenomyosis lesions},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {26},
doi = {10.1126/sciadv.aea6379}
}
EUVIMED